Form 4 for RIGL RIGEL PHARMACEUTICALS INC
Accepted 2026-09-03 18:59:51 ET · period of report 2026-09-01 · accession 0000905148-26-004078 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 18:59 | 2026-09-01 | RIGL | RODRIGUEZ RAUL R | CEO, Pres, Dir | F - Tax | $47.50 | -2,424 | 273.4K | -0.9% | -$115.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-01 | F | D | 2,424 | $47.50 | 273,362 | D | — | — | (F1) Reflects the return to the Issuer of 3,807 shares previously reported as acquired under the Issuer's employee stock purchase plan. |